This PDF is the current document as it appeared on Public Inspection on 05/31/2017 at 08:45 am.
Notice of registration.
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of controlled substances.End Preamble Start Supplemental Information
The companies listed below applied to be registered as manufacturers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices.
|Cody Laboratories, Inc||81 FR 61249||September 6, 2016.|
|Alcami Wisconsin Corporation||81 FR 63219||September 14, 2016.|
|Johnson Matthey, Inc||81 FR 71767||October 18, 2016.|
|Noramco, Inc||82 FR 6645||January 19, 2017.|
|Organix, Inc||82 FR 8433||January 25, 2017.|
|Mallinckrodt, LLC||82 FR 13136||March 9, 2017.|
|Siemens Healthcare Diagnostics, Inc||82 FR 13506||March 13, 2017.|
The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.Start Signature
Dated: May 23, 2017.
Louis J. Milione,
[FR Doc. 2017-11383 Filed 5-31-17; 8:45 am]
BILLING CODE 4410-09-P